These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

338 related items for PubMed ID: 12015744

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The dichotomy in the preinvasive neoplasia to invasive carcinoma sequence in the pancreas: differential expression of MUC1 and MUC2 supports the existence of two separate pathways of carcinogenesis.
    Adsay NV, Merati K, Andea A, Sarkar F, Hruban RH, Wilentz RE, Goggins M, Iocobuzio-Donahue C, Longnecker DS, Klimstra DS.
    Mod Pathol; 2002 Oct; 15(10):1087-95. PubMed ID: 12379756
    [Abstract] [Full Text] [Related]

  • 6. The expression of several types of mucin is related to the biological behavior of pancreatic neoplasms.
    Yonezawa S, Nakamura A, Horinouchi M, Sato E.
    J Hepatobiliary Pancreat Surg; 2002 Oct; 9(3):328-41. PubMed ID: 12353144
    [Abstract] [Full Text] [Related]

  • 7. Intraductal papillary mucinous neoplasm (IPMN) of the pancreas: its histopathologic difference between 2 major types.
    Ban S, Naitoh Y, Mino-Kenudson M, Sakurai T, Kuroda M, Koyama I, Lauwers GY, Shimizu M.
    Am J Surg Pathol; 2006 Dec; 30(12):1561-9. PubMed ID: 17122512
    [Abstract] [Full Text] [Related]

  • 8. Frequency of subtypes of biliary intraductal papillary mucinous neoplasm and their MUC1, MUC2, and DPC4 expression patterns differ from pancreatic intraductal papillary mucinous neoplasm.
    Sclabas GM, Barton JG, Smyrk TC, Barrett DA, Khan S, Kendrick ML, Reid-Lombardo KM, Donohue JH, Nagorney DM, Que FG.
    J Am Coll Surg; 2012 Jan; 214(1):27-32. PubMed ID: 22112419
    [Abstract] [Full Text] [Related]

  • 9. Differential roles of alterations of p53, p16, and SMAD4 expression in the progression of intraductal papillary-mucinous tumors of the pancreas.
    Sasaki S, Yamamoto H, Kaneto H, Ozeki I, Adachi Y, Takagi H, Matsumoto T, Itoh H, Nagakawa T, Miyakawa H, Muraoka S, Fujinaga A, Suga T, Satoh M, Itoh F, Endo T, Imai K.
    Oncol Rep; 2003 Jan; 10(1):21-5. PubMed ID: 12469138
    [Abstract] [Full Text] [Related]

  • 10. Comparison of histologic subtype and growth pattern in intraductal papillary-mucinous carcinoma of the pancreas.
    Sanada Y, Kunita S, Yoshida K.
    Oncol Rep; 2008 Jun; 19(6):1435-43. PubMed ID: 18497948
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The immunohistochemical mucin expression pattern distinguishes different types of intraductal papillary mucinous neoplasms of the pancreas and determines their relationship to mucinous noncystic carcinoma and ductal adenocarcinoma.
    Lüttges J, Zamboni G, Longnecker D, Klöppel G.
    Am J Surg Pathol; 2001 Jul; 25(7):942-8. PubMed ID: 11420467
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Mucin expression profile is related to biological and clinical characteristics of intraductal papillary-mucinous tumors of the pancreas.
    Ito H, Endo T, Oka T, Matumoto T, Abe T, Toyota M, Imai K, Satoh M, Maguchi H, Shinohara T.
    Pancreas; 2005 May; 30(4):e96-102. PubMed ID: 15841035
    [Abstract] [Full Text] [Related]

  • 16. Progressive genomic alterations in intraductal papillary mucinous tumours of the pancreas and morphologically similar lesions of the pancreatic ducts.
    Soldini D, Gugger M, Burckhardt E, Kappeler A, Laissue JA, Mazzucchelli L.
    J Pathol; 2003 Apr; 199(4):453-61. PubMed ID: 12635136
    [Abstract] [Full Text] [Related]

  • 17. MUC1 and MUC2 expression in pancreatic ductal carcinoma obtained by fine-needle aspiration.
    Chhieng DC, Benson E, Eltoum I, Eloubeidi MA, Jhala N, Jhala D, Siegal GP, Grizzle WE, Manne U.
    Cancer; 2003 Dec 25; 99(6):365-71. PubMed ID: 14681945
    [Abstract] [Full Text] [Related]

  • 18. [Clinical and morphological characteristics of intraductal papillary mucinous tumors of the pancreas].
    Dubova EA, Shchegolev AI.
    Arkh Patol; 2009 Dec 25; 71(2):9-12. PubMed ID: 19507570
    [Abstract] [Full Text] [Related]

  • 19. Molecular profile of apomucin and p53 protein as predictors of malignancy in intraductal papillary mucinous neoplasms of the pancreas.
    Mizumoto M, Honjo G, Kobashi Y, Awane M, Matsusue S.
    Hepatogastroenterology; 2011 Dec 25; 58(110-111):1791-5. PubMed ID: 22086702
    [Abstract] [Full Text] [Related]

  • 20. Comparative analysis of K-ras point mutation, telomerase activity, and p53 overexpression in pancreatic tumours.
    Uemura K, Hiyama E, Murakami Y, Kanehiro T, Ohge H, Sueda T, Yokoyama T.
    Oncol Rep; 2003 Dec 25; 10(2):277-83. PubMed ID: 12579258
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.